{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:34:23Z","timestamp":1761489263628},"reference-count":48,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2013,12,2]],"date-time":"2013-12-02T00:00:00Z","timestamp":1385942400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0082134","type":"journal-article","created":{"date-parts":[[2013,12,2]],"date-time":"2013-12-02T21:48:12Z","timestamp":1386020892000},"page":"e82134","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":7,"title":["Lysophosphatidic Acid Enhances Stromal Cell-Directed Angiogenesis"],"prefix":"10.1371","volume":"8","author":[{"given":"Bernard Y. K.","family":"Binder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claus S.","family":"Sondergaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan A.","family":"Nolta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Kent","family":"Leach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,12,2]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"e5208","DOI":"10.1136\/bmj.e5208","article-title":"Diagnosis and management of peripheral arterial disease","volume":"345","author":"G Peach","year":"2012","journal-title":"BMJ"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2147\/vhrm.2007.3.2.229","article-title":"Epidemiology, classification, and modifiable risk factors of peripheral arterial disease","volume":"3","author":"NW Shammas","year":"2007","journal-title":"Vasc Health Risk Manag"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/j.1538-7836.2007.02386.x","article-title":"Spatiotemporal control of vascular endothelial growth factor delivery from injectable hydrogels enhances angiogenesis","volume":"5","author":"EA Silva","year":"2007","journal-title":"J Thromb Haemost"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nature04483","article-title":"Angiogenesis as a therapeutic target","volume":"438","author":"N Ferrara","year":"2005","journal-title":"Nature"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"14347","DOI":"10.1073\/pnas.0803873105","article-title":"Material-based deployment enhances efficacy of endothelial progenitor cells","volume":"105","author":"EA Silva","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"77","DOI":"10.5551\/jat.13.77","article-title":"Adipose tissue-derived stromal cells as a novel option for regenerative cell therapy","volume":"13","author":"H Nakagami","year":"2006","journal-title":"J Atheroscler Thromb"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1161\/ATVBAHA.113.301217","article-title":"Perivascular Delivery of Encapsulated Mesenchymal Stem Cells Improves Postischemic Angiogenesis Via Paracrine Activation of VEGF-A","volume":"33","author":"R Katare","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"554","DOI":"10.3109\/14653241003709694","article-title":"Osteogenic comparison of expanded and uncultured adipose stromal cells","volume":"12","author":"WK Cheung","year":"2010","journal-title":"Cytotherapy"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ymeth.2008.03.006","article-title":"Adipose-derived stem cells: isolation, expansion and differentiation","volume":"45","author":"BA Bunnell","year":"2008","journal-title":"Methods"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nrd3055","article-title":"Adipose tissue angiogenesis as a therapeutic target for obesity and metabolic diseases","volume":"9","author":"Y Cao","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s12015-009-9084-y","article-title":"Adipose derived stem cells and smooth muscle cells: implications for regenerative medicine","volume":"5","author":"JA de Villiers","year":"2009","journal-title":"Stem Cell Rev"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/jcb.22514","article-title":"Oxygen tension differentially influences osteogenic differentiation of human adipose stem cells in 2D and 3D cultures","volume":"110","author":"J He","year":"2010","journal-title":"J Cell Biochem"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1476-5381.2010.00815.x","article-title":"Aiming drug discovery at lysophosphatidic acid targets","volume":"161","author":"G Tigyi","year":"2010","journal-title":"Br J Pharmacol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"12949","DOI":"10.1074\/jbc.270.22.12949","article-title":"Lysophosphatidic acid, a multifunctional phospholipid messenger","volume":"270","author":"WH Moolenaar","year":"1995","journal-title":"J Biol Chem"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1634\/stemcells.2007-0098","article-title":"Lysophosphatidic acid protects mesenchymal stem cells against hypoxia and serum deprivation-induced apoptosis","volume":"26","author":"J Chen","year":"2008","journal-title":"Stem Cells"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.bone.2005.12.013","article-title":"Lysophosphatidic acid induces chemotaxis in MC3T3-E1 osteoblastic cells","volume":"39","author":"LM Masiello","year":"2006","journal-title":"Bone"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.bbalip.2012.04.005","article-title":"Lysophosphatidic acid, human osteoblast formation, maturation and the role of 1alpha,25-Dihydroxyvitamin D3 (calcitriol)","volume":"1831","author":"JP Mansell","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/jcb.21641","article-title":"Lysophosphatidic acid in malignant ascites stimulates migration of human mesenchymal stem cells","volume":"104","author":"MJ Lee","year":"2008","journal-title":"J Cell Biochem"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3858\/emm.2010.42.4.027","article-title":"Ovarian cancer-derived lysophosphatidic acid stimulates secretion of VEGF and stromal cell-derived factor-1 alpha from human mesenchymal stem cells","volume":"42","author":"ES Jeon","year":"2010","journal-title":"Exp Mol Med"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.canlet.2007.08.011","article-title":"Hypoxia enhances LPA-induced HIF-1alpha and VEGF expression: their inhibition by resveratrol","volume":"258","author":"SY Park","year":"2007","journal-title":"Cancer Lett"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"6351","DOI":"10.1158\/1078-0432.CCR-06-1252","article-title":"Activation of hypoxia-inducible factor-1alpha is necessary for lysophosphatidic acid-induced vascular endothelial growth factor expression","volume":"12","author":"J Lee","year":"2006","journal-title":"Clin Cancer Res"},{"key":"ref22","article-title":"Lysophosphatidic acid protects human mesenchymal stromal cells from differentiation-dependent vulnerability to apoptosis","author":"BY Binder","year":"2013","journal-title":"Tissue Eng Part A."},{"key":"ref23","doi-asserted-by":"crossref","first-page":"e35579","DOI":"10.1371\/journal.pone.0035579","article-title":"Differentiation-dependent secretion of proangiogenic factors by mesenchymal stem cells","volume":"7","author":"AI Hoch","year":"2012","journal-title":"PLOS ONE"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.actbio.2010.09.007","article-title":"Supplementation of fibrin gels with sodium chloride enhances physical properties and ensuing osteogenic response","volume":"7","author":"HE Davis","year":"2011","journal-title":"Acta Biomater"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1186\/1756-0500-5-423","article-title":"A reproducible, high throughput method for fabricating fibrin gels","volume":"5","author":"KC Murphy","year":"2012","journal-title":"BMC Res Notes"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1002\/stem.720","article-title":"Effects on proliferation and differentiation of multipotent bone marrow stromal cells engineered to express growth factors for combined cell and gene therapy","volume":"29","author":"FA Fierro","year":"2011","journal-title":"Stem Cells"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1089\/ten.tea.2009.0255","article-title":"Osteogenesis and trophic factor secretion are influenced by the composition of hydroxyapatite\/poly(lactide-co-glycolide) composite scaffolds","volume":"16","author":"J He","year":"2010","journal-title":"Tissue Eng Part A"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1749-6632.2001.tb03526.x","article-title":"Role of fibrin matrix in angiogenesis","volume":"936","author":"VW van Hinsbergh","year":"2001","journal-title":"Ann N Y Acad Sci"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10439-010-0135-y","article-title":"Designing bioactive delivery systems for tissue regeneration","volume":"39","author":"HE Davis","year":"2011","journal-title":"Ann Biomed Eng"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s11095-009-0014-0","article-title":"Sustained release of multiple growth factors from injectable polymeric system as a novel therapeutic approach towards angiogenesis","volume":"27","author":"Q Sun","year":"2010","journal-title":"Pharm Res"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1096\/fasebj.13.1.9","article-title":"Vascular endothelial growth factor (VEGF) and its receptors","volume":"13","author":"G Neufeld","year":"1999","journal-title":"FASEB J"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.cyto.2010.06.012","article-title":"Vascular endothelial growth factor inhibition: conflicting roles in tumor growth","volume":"53","author":"M Saranadasa","year":"2011","journal-title":"Cytokine"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1096\/fj.02-1041fje","article-title":"Cell-demanded release of VEGF from synthetic, biointeractive cell ingrowth matrices for vascularized tissue growth","volume":"17","author":"AH Zisch","year":"2003","journal-title":"FASEB J"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.bbrc.2012.06.080","article-title":"Sustained delivery of VEGF from designer self-assembling peptides improves cardiac function after myocardial infarction","volume":"424","author":"HD Guo","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"6080","DOI":"10.1016\/j.biomaterials.2011.05.003","article-title":"The enhancement of mature vessel formation and cardiac function in infarcted hearts using dual growth factor delivery with self-assembling peptides","volume":"32","author":"JH Kim","year":"2011","journal-title":"Biomaterials"},{"key":"ref36","article-title":"R&D Systems Annual Catalog","author":"Systems RD","year":"2012"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrm1103","article-title":"Sphingosine-1-phosphate: an enigmatic signalling lipid","volume":"4","author":"S Spiegel","year":"2003","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1161\/01.ATV.0000254669.12675.70","article-title":"Sphingosine-1-phosphate stimulates the functional capacity of progenitor cells by activation of the CXCR4-dependent signaling pathway via the S1P3 receptor","volume":"27","author":"DH Walter","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"125","DOI":"10.5551\/jat.10.125","article-title":"Sphingosine-1-phosphate signaling in endothelial activation","volume":"10","author":"H Ozaki","year":"2003","journal-title":"J Atheroscler Thromb"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1161\/01.RES.0000182903.16652.d7","article-title":"Endothelial\/pericyte interactions","volume":"97","author":"A Armulik","year":"2005","journal-title":"Circ Res"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1089\/scd.2008.0352","article-title":"Lysophosphatidic acid protects mesenchymal stem cells against ischemia-induced apoptosis in vivo","volume":"18","author":"X Liu","year":"2009","journal-title":"Stem Cells Dev"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"e2934","DOI":"10.1371\/journal.pone.0002934","article-title":"Murine mesenchymal stem cells exhibit a restricted repertoire of functional chemokine receptors: comparison with human","volume":"3","author":"G Chamberlain","year":"2008","journal-title":"PLOS ONE"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1089\/jir.2008.0027","article-title":"Monocyte chemoattractant protein-1 (MCP-1): an overview","volume":"29","author":"SL Deshmane","year":"2009","journal-title":"J Interferon Cytokine Res"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s10456-008-9113-5","article-title":"Lysophosphatidic acid (LPA) and angiogenesis","volume":"11","author":"CM Rivera-Lopez","year":"2008","journal-title":"Angiogenesis"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.bbalip.2008.05.004","article-title":"Sphingosine 1-phosphate, lysophosphatidic acid and growth factor signaling and termination","volume":"1781","author":"NJ Pyne","year":"2008","journal-title":"Biochim Biophys Acta"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"13785","DOI":"10.1073\/pnas.1221309110","article-title":"Sphingosine 1-phosphate receptor 3 regulates recruitment of anti-inflammatory monocytes to microvessels during implant arteriogenesis","volume":"110","author":"AO Awojoodu","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1080\/14653240801982979","article-title":"Characterization of adipose tissue-derived cells isolated with the Celution system","volume":"10","author":"K Lin","year":"2008","journal-title":"Cytotherapy"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1479-5876-7-29","article-title":"Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosis","volume":"7","author":"NH Riordan","year":"2009","journal-title":"J Transl Med"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0082134","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T21:08:32Z","timestamp":1716239312000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0082134"}},"subtitle":[],"editor":[{"given":"Graca","family":"Almeida-Porada","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,12,2]]},"references-count":48,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2013,12,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0082134","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,2]]}}}